Showing results (71-80 of 213) with videos related to

Sort By:
Pageof 22
Nature Reviews. Cancer|April 27, 2018
Oncolytic viruses as engineering platforms for combination immunotherapyKwame Twumasi-Boateng, Jessica L Pettigrew, Y Y Eunice Kwok, et al.
Journal of the American Chemical Society|September 29, 2012
Anti-Fab aptamers for shielding virus from neutralizing antibodiesDarija Muharemagic, Mahmoud Labib, Shahrokh M Ghobadloo, et al.
Current Opinion in Virology|April 23, 2015
Pexa-Vec double agent engineered vaccinia: oncolytic and active immunotherapeuticCaroline J Breitbach, Kelley Parato, James Burke, et al.
Cytokine & Growth Factor Reviews|July 29, 2020
Engineering and combining oncolytic measles virus for cancer therapyMathias F Leber, Serge Neault, Elise Jirovec, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 30, 2003
Novel immunocompetent murine tumor models for the assessment of replication-competent oncolytic adenovirus efficacyGunnel Halldén, Richard Hill, Yaohe Wang, et al.
Scientific Reports|July 13, 2017
Tudor Domain Containing Protein 3 Promotes Tumorigenesis and Invasive Capacity of Breast Cancer CellsAlan Morettin, Geneviève Paris, Younes Bouzid, et al.
Molecular Therapy. Nucleic Acids|June 4, 2014
Aptamer-facilitated Protection of Oncolytic Virus from Neutralizing AntibodiesDarija Muharemagic, Anna Zamay, Shahrokh M Ghobadloo, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 19, 2008
A let-7 MicroRNA-sensitive vesicular stomatitis virus demonstrates tumor-specific replicationRobert E Edge, Theresa J Falls, Christopher W Brown, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 27, 2014
Bacterial-mediated knockdown of tumor resistance to an oncolytic virus enhances therapyMichelle Cronin, Fabrice Le Boeuf, Carola Murphy, et al.
Pageof 22